Brolucizumab for treating neovascular age-related macular degeneration: An alternative for treatment-refractory patients

被引：0
|
作者：
Groen, Martin Biilmann [1 ]
Vestergaard, Anders Hojslet [1 ,2 ]
Cehofski, Lasse Jorgensen [1 ,2 ]
机构：
[1] Odense Univ Hosp, Dept Ophthalmol, Odense, Denmark
[2] Univ Southern Denmark, Clin Inst, Res Unit Ophthalmol, Odense, Denmark
来源：
ACTA OPHTHALMOLOGICA | 2025年
关键词：
D O I：
10.1111/aos.17446
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Treatment of neovascular age-related macular degeneration in patients with diabetes
    Cummings, Michael
    Cunha-Vaz, Jose
    CLINICAL OPHTHALMOLOGY, 2008, 2 (02): : 369 - 375
  • [22] Intravitreal brolucizumab in neovascular age-related macular degeneration with limited response to aflibercept
    Hatz, Katja B.
    Cedro, Luca
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [23] Brolucizumab and fluid in neovascular age-related macular degeneration (n-AMD)
    Ashish Sharma
    Nilesh Kumar
    Nikulaa Parachuri
    Rohini Sharma
    Francesco Bandello
    Baruch D. Kuppermann
    Carl D. Regillo
    Eye, 2020, 34 : 1310 - 1312
  • [24] Brolucizumab and fluid in neovascular age-related macular degeneration (n-AMD)
    Sharma, Ashish
    Kumar, Nilesh
    Parachuri, Nikulaa
    Sharma, Rohini
    Bandello, Francesco
    Kuppermann, Baruch D.
    Regillo, Carl D.
    EYE, 2020, 34 (08) : 1310 - 1312
  • [25] Evaluation of cardiac parameters and other safety outcomes of brolucizumab treatment in patients with neovascular age-related macular degeneration
    Zakaria, Nadia
    Guerard, Nicolas
    Emanuelli, Andres
    Dugel, Pravin
    Watts, Jen
    Liew, Melissa
    Gekkieva, Margarita
    Hinder, Markus
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2022, 10 (02):
  • [26] One-year outcome of brolucizumab for neovascular age-related macular degeneration in Japanese patients
    Inoda, Satoru
    Takahashi, Hidenori
    Takahashi, Ryota
    Hashimoto, Yuto
    Yoshida, Hana
    Tsukii, Rika
    Takahashi, Hironori
    Kawashima, Hidetoshi
    Yanagi, Yasuo
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [27] One-year outcome of brolucizumab for neovascular age-related macular degeneration in Japanese patients
    Satoru Inoda
    Hidenori Takahashi
    Ryota Takahashi
    Yuto Hashimoto
    Hana Yoshida
    Rika Tsukii
    Hironori Takahashi
    Hidetoshi Kawashima
    Yasuo Yanagi
    Scientific Reports, 14
  • [28] Factors Associated With Intraocular Inflammation in Neovascular Age-Related Macular Degeneration Patients Treated With Brolucizumab
    Hashimoto, Yuto
    Inoda, Satoru
    Takahashi, Hidenori
    Takahashi, Ryota
    Yoshida, Hana
    Fujino, Yujiro
    Sakamoto, Shinichi
    Kawashima, Hidetoshi
    Yanagi, Yasuo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (01)
  • [29] The effect of brolucizumab applied by microvolume injection or infusion in patients with neovascular age-related macular degeneration
    Jhaveri, Chirag
    Wenzel, Andreas
    Weichselberger, Andreas
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [30] Factors Associated with Injection Interval in Refractory Neovascular Age related Macular Degeneration Patients Switched to Brolucizumab
    Hyun, Lee Jeong
    Shin, Jooyoung
    Ahn, Jeeyun
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
12345